A polymorphism in endostatin, an angiogenesis inhibitor, predisposes for the development of prostatic adenocarcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/11606364

Cancer Res. 2001 Oct 15 61 20 7375-8

Download in:

View as

Triples

General Info

PMID
11606364